Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma.
Authors: Zhang C; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Kuo JC; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Huang Y; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Hu Y; The Whiteoak Group, Inc., Rockville, MD 20855, USA., Deng L; The Whiteoak Group, Inc., Rockville, MD 20855, USA., Yung BC; The Whiteoak Group, Inc., Rockville, MD 20855, USA., Zhao X; The Whiteoak Group, Inc., Rockville, MD 20855, USA., Zhang Z; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA., Pan J; William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210, USA., Ma Y; William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210, USA., Lee RJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Source: Pharmaceutics [Pharmaceutics] 2023 Nov 25; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 25.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1999-4923
DOI:10.3390/pharmaceutics15122674